Division of Infectious Diseases, SUNY-Downstate, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.
J Clin Microbiol. 2011 Nov;49(11):3931-3. doi: 10.1128/JCM.01176-11. Epub 2011 Aug 31.
Using the updated 2010 CLSI carbapenem breakpoints for the Enterobacteriaceae, nonsusceptibility to ertapenem and imipenem predicted the presence of bla(KPC) poorly, especially among Escherichia coli and Enterobacter species. In regions where KPC-producing bacteria are endemic, testing for nonsusceptibility to meropenem may provide improved accuracy in identifying these isolates.
采用更新的 2010 年 CLSI 碳青霉烯类药物药敏折点,对于肠杆菌科细菌,厄他培南和亚胺培南的耐药性并不能很好地预测 bla(KPC)的存在,尤其是在大肠埃希菌和肠杆菌属细菌中。在产 KPC 细菌流行的地区,检测美罗培南的耐药性可能会提高识别这些分离株的准确性。